Despite the diversity of topics and speakers, some common threads emerged at the joint structural biology meetings in Keystone this past week. First, structural genomics clearly has hit its stride.

– Data support the potential of verekitug’s unique mechanism of action to achieve a differentiated therapeutic effect across a broad range of TSLP-driven severe respiratory diseases – “We continue to ...